Vernodalin
Vernodalin is an orally active, cytotoxic sesquiterpene lactone with a Kd value of 9.55 μM for p38 MAPK. Vernodalin downregulates the expression of phosphorylated ERK, JNK, AKT, PI3K, mTOR, p38MAPK, FAK, MMP-2, MMP-9, and uPA, while upregulates the expression of TIMP-1 and TIMP-2. Vernodalin increases ROS production, upregulates the expression of Bax and caspase 3, downregulates the expression of Bcl-2, and induces apoptosis (apoptosis), oxidative stress response and cell cycle arrest. Vernodalin inhibits the proliferation, adhesion and metastasis of cancer cells. Vernodalin enhances the activity of VEGF-B, AMPK and eNOS signaling pathways. Vernodalin alleviates myocardial injury and restores hemodynamic parameters. Vernodalin inhibits the growth of Trypanosoma brucei rhodesiense. Vernodalin can be used in research related to various cancers including gastric cancer, colorectal cancer and lung cancer, as well as African human trypanosomiasis and myocardial infarction.
For research use only. We do not sell to patients.
- CAS No.: 21871-10-3
- Formula: C19H20O7
- Molecular Weight:360.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
0.4 μM
Compound: 4
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
| HCT-116 | IC50 |
3.17 μM
Compound: 6
|
Cytotoxicity against human HCT-116 cells incubated for 24 hrs by MTT assay
Cytotoxicity against human HCT-116 cells incubated for 24 hrs by MTT assay
|
[PMID: 38142509] |
| HCT-116 | IC50 |
315.8 μM
Compound: 6
|
Antiproliferative activity in human HCT-116 cells measured after 12 to 24 hrs by MTT assay
Antiproliferative activity in human HCT-116 cells measured after 12 to 24 hrs by MTT assay
|
[PMID: 38142509] |
| HeLa | IC50 |
0.2 μM
Compound: 4
|
Antiproliferation activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferation activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
| HT-29 | IC50 |
7.17 μM
Compound: 6
|
Cytotoxicity against human HT-29 cells incubated for 24 hrs by MTT assay
Cytotoxicity against human HT-29 cells incubated for 24 hrs by MTT assay
|
[PMID: 38142509] |
| MDA-MB-231 | IC50 |
0.3 μM
Compound: 4
|
Antiproliferation activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
Antiproliferation activity against human MDA-MB-231 cells assessed as reduction in cell viability after 72 hrs by WST-8 assay
|
[PMID: 27311895] |
| SW-620 | IC50 |
355.1 μM
Compound: 6
|
Antiproliferative activity in human SW620 cells measured after 12 to 24 hrs by MTT assay
Antiproliferative activity in human SW620 cells measured after 12 to 24 hrs by MTT assay
|
[PMID: 38142509] |
In Vitro
Vernodalin (5-40 μM; 24 h) inhibits the proliferation and induces apoptosis of SGC-7901 and AGS cells in a concentration-dependent manner, increases the levels of nuclear pyknosis and fragmentation, and induces a significant decrease in mitochondrial membrane potential[1].
Vernodalin (20 μM; 24 h pre-incubation, 60 and 100 min adhesion period) reduces the adhesion of SGC-7901 and AGS cells to extracellular matrix components at the 60 and 100 min time points[1].
Vernodalin (20 μM; 24 h) downregulates the protein expression of uPA, MMP-2 and MMP-9, while upregulates the protein expression of TIMP-1 and TIMP-2 in SGC-7901 and AGS cells. It inhibits the FAK/PI3K/AKT/mTOR signaling pathway by reducing the protein expression of FAK, p-PI3K, p-AKT, p-mTOR and RhoA in cells, and inhibits the MAPKs signaling pathway by reducing the protein expression of phosphorylated JNK, JUN, p38MAPK and ERK in cells[1].
Vernodalin (3.12-150 µM; 24 h) reduces the viability of HT-29 and HCT116 cells in a dose-dependent manner, with IC50 values of 7.17 µg/mL and 3.17 µg/mL, respectively[3].
Vernodalin (1-20 μM; 24-72 h) inhibits the proliferation of A549 lung cancer cells in a time-dependent manner, with IC50 values of 65.80 μM (24 h), 39.90 μM (48 h), and 25.85 μM (72 h), respectively[4].
Vernodalin (0.016-50 μg/mL; 48 h) potently inhibits the viability of a variety of human cancer cell lines (A549, HeLa, HuCCA-1, HepG2, H69AR, T47-D, MDA-MB-231, S102, HL-60, MOLT-3), with IC50 values ranging from 2.28 μM to 21.47 μM, and exhibits selective cytotoxicity toward cancer cells compared to normal MRC-5 fibroblasts[6].
Vernodalin (3-12 h) induces time-dependent oxidative stress in HT-29 and HCT116 cells by increasing ROS production, which is associated with cell necrosis and apoptosis[3].
Vernodalin (5-15 µg/mL for HT-29, 2.5-10 µg/mL for HCT116; 24 h) induces apoptosis in HT-29 and HCT116 cells in a dose-dependent manner, upregulates the expression of Bax and caspase 3, downregulates the expression of Bcl-2, and thereby increases the Bax/Bcl-2 ratio[3].
Vernodalin (10 μM; 48 h) [missing action in source text], accompanied by observable morphological changes in cells[6].
Vernodalin (5-20 µg/mL; 1.5-24 h) activates the JNK, ERK and p38 MAPK pathways in HT-29 and HCT116 cells in a time- and dose-dependent manner[3].
Vernodalin (26 μM; 72 h) induces excessive ROS production in A549 lung cancer cells[4].
Vernodalin (26 μM; 72 h) enhances oxidative stress in A549 lung cancer cells by increasing MDA levels and reducing the antioxidant defense capacities of SOD, CAT, GPX and GSH. It also impairs the endogenous antioxidant defense system by decreasing the mRNA expression levels of Nrf2 and HO-1, as well as the enzymatic activity of HO-1[4].
Vernodalin (26 μM; 72 h) activates the pro-apoptotic signaling pathway in A549 lung cancer cells by upregulating the mRNA expression of p38 MAPK, caspase-3, caspase-9 and Bax, downregulating the mRNA expression of Bcl-2, and increasing the activities of caspase-3 and caspase-9[4].
Vernodalin potently inhibits the growth of bloodstream-form trypomastigotes of *Trypanosoma brucei rhodesiense* (strain STIB 900), with an IC50 value of 0.16 µM[5].
Vernodalin (10 μM; 48 h) induces apoptosis in 10.9% of HepG2 cells, triggers G2/M phase cell cycle arrest, and reduces the proportions of cells in the G0/G1 and S phases[6].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SGC-7901 and AGS cells
-
Concentration:5, 10, 20, 30, 40 μM
-
Incubation Time:24 h
-
Result:Exerted concentration-dependent cytotoxic and anti-proliferative effects on both SGC-7901 and AGS cells.
Showed the strongest inhibition of cell proliferation at the highest tested concentration (40 μM).
Determined an IC50 corresponding to the 20 μM concentration selected for subsequent experiments.
Caused statistically significant reductions in cell viability at all tested concentrations compared to untreated controls.
-
Cell Line:human gastric cancer SGC-7901 and AGS cells
-
Concentration:20 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis in SGC-7901 and AGS cells, as evidenced by a significant increase in cells with bright nuclear condensation or fragmented nuclei compared to untreated controls.
Caused statistically significant increases in apoptosis rate, with apoptosis rates rising to ~60% in SGC-7901 cells and ~60% in AGS cells.
-
Cell Line:human gastric cancer SGC-7901 and AGS cells
-
Concentration:20 μM
-
Incubation Time:24 h
-
Result:Down-regulated protein expression of uPA, MMP-2, and MMP-9 in both SGC-7901 and AGS cells.
Up-regulated protein expression of TIMP-1 and TIMP-2 in both SGC-7901 and AGS cells.
Caused statistically significant changes in fold expression compared to untreated controls.\nReduced protein expression of FAK, p-PI3K, p-AKT, p-mTOR, and RhoA in both SGC-7901 and AGS cells compared to untreated controls.
Caused statistically significant reductions in fold expression.\nReduced protein expression of p-JNK, p-JUN, p-p38MAPK, and p-ERK in both SGC-7901 and AGS cells compared to untreated controls.
Caused statistically significant reductions in fold expression.
-
Cell Line:A549 lung cancer cells
-
Concentration:26 μM
-
Incubation Time:72 h
-
Result:Significantly reduced HO-1 mRNA expression, HO-1 enzyme activity, and Nrf2 mRNA expression in A549 cells compared to control.\nIncreased p38 MAPK, caspase-3, caspase-9, and Bax mRNA expression in A549 cells compared to control.
Decreased Bcl-2 mRNA expression in A549 cells compared to control.
Increased the Bax/Bcl-2 mRNA ratio in A549 cells compared to control.
Increased caspase-3 and caspase-9 activity in A549 cells compared to control.
-
Cell Line:A549, HeLa, HuCCA-1, HepG2, H69AR, T47-D, MDA-MB-231, S102, HL-60, MOLT-3, MRC-5
-
Concentration:50, 10, 2.0, 0.40, 0.08, and 0.016 μg/mL
-
Incubation Time:48 h
-
Result:Exhibited cytotoxic activity across all tested cancer cell lines with IC50 values: A549 (13.61 μM), HeLa (3.81 μM), HuCCA-1 (8.17 μM), HepG2 (15.47 μM), H69AR (21.47 μM), T47-D (6.86 μM), MDA-MB-231 (16.14 μM), S102 (21.47 μM), HL-60 (2.28 μM), MOLT-3 (3.92 μM).
Showed low toxicity to normal MRC-5 cells with an IC50 of 69.83 μM, resulting in selectivity index (SI) values ≥3.0 for all cancer cell lines (HeLa SI=18.3, H69AR SI=3.3).
-
Cell Line:HepG2
-
Concentration:10 μM
-
Incubation Time:48 h
-
Result:Altered HepG2 cell cycle distribution: 47.9% of cells in G0/G1 phase, 10.3% in S phase, and 41.6% in G2/M phase, compared to control values of 49.8% (G0/G1), 11.6% (S), and 38.4% (G2/M).
Reduced G0/G1 and S phase populations and increased G2/M phase populations relative to controls.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar albino (male, 140-180 g, isoproterenol-induced myocardial infarction)[2]
-
Dosage:10 mg/kg bw
-
Administration:p.o.; daily; 30 days
-
Result:Significantly reduced heart weight and heart weight/body weight index compared to isoproterenol-only rats.
Restored diastolic arterial pressure, systolic arterial pressure, mean arterial pressure, and heart rate to near-normal levels.
Significantly decreased serum levels of cardiotoxicity enzymes (AST, LDH, CK), cardiac biomarkers (H-FABP, MYO, CK-MB, GP-BBP, TGF-β, cTnI, BNP), and myocardial protein levels of inflammatory mediators (TNF-α, IL-6, NF-κB) compared to isoproterenol-only rats.
Significantly increased myocardial protein levels of VEGF-B, phosphorylated AMPK, and the phosphorylated eNOS/eNOS ratio compared to isoproterenol-only rats.
Reduced histopathological damage (necrosis, inflammatory cell infiltration, fragmented myofibrils) to near-normal levels, with a significantly lower histology damage score than isoproterenol-only rats.
Chemical Information
-
CAS No. 21871-10-3
-
Molecular Weight 360.36
-
Formula C19H20O7
-
SMILES
C(=C)[C@@]12[C@@]([C@@]3([C@@]([C@@H](OC(C(CO)=C)=O)C1)(C(=C)C(=O)O3)[H])[H])(C(=C)C(=O)OC2)[H]
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Orthotopic Cell-Line Xenograft
Orthotopic cell-line xenograft models involve implantation of human cancer cell lines into the anatomically corresponding organ of immunodeficient mice to reproduce tumor growth within a native microenvironment, enabling more clinically relevant tumor behavior compared with subcutaneous models. These models are widely used because orthotopic placement better recapitulates tumor progression, including invasion and metastatic spread, which are often underrepresented in heterotopic implantation systems. Compared with conventional xenografts, orthotopic implantation is described as more technically complex but provides improved simulation of tumor-microenvironment interactions and metastatic behavior, making it particularly valuable for translational oncology research. Surgical orthotopic implantation approaches have been emphasized as enabling faithful reproduction of clinical cancer features, including metastasis and disease progression patterns that align with the tumor’s organ of origi
Purity & Documentation
References
[1]. Luo Y, et al. Vernodalin Suppresses Tumor Proliferation and Increases Apoptosis of Gastric Cancer Cells Through Attenuation of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways. Current pharmaceutical biotechnology. 2023;24(5):708-717. [Content Brief]
[2]. Tao T, et al. Vernodalin Alleviates Cardiotoxicity and Inflammation in Isoproterenol-Mediated Myocardial Infarction through NF-κB/AMPK Signaling Pathways in Rats. Comb Chem High Throughput Screen. 2025;28(9):1594-1603. [Content Brief]
[3]. Mohebali N, et al. Vernodalin induces apoptosis through the activation of ROS/JNK pathway in human colon cancer cells. Journal of biochemical and molecular toxicology. 2020 Dec;34(12):e22587. [Content Brief]
[4]. Zhou J, et al. Interaction of vernodalin with p38 mitogen-activated protein kinase (p38 MAPK) and subsequent effects in lung cancer cell model. International journal of biological macromolecules. 2025 Jun;311(Pt 1):143413. [Content Brief]
[5]. Kimani NM, et al. Sesquiterpene Lactones from Vernonia cinerascens Sch. Bip. and Their in Vitro Antitrypanosomal Activity. Molecules (Basel, Switzerland). 2018 Jan 27;23(2):248. [Content Brief]
[6]. Thongnest S, et al. Vernodalidimer L, a sesquiterpene lactone dimer from Vernonia extensa and anti-tumor effects of vernodalin, vernolepin, and vernolide on HepG2 liver cancer cells. Bioorganic chemistry. 2019 Nov;92:103197. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Vernodalin
- 21871-10-3
- p38 MAPK
- PERK
- JNK
- Akt
- PI3K
- mTOR
- FAK
- MMP
- PAI-1
- Reactive Oxygen Species (ROS)
- Caspase
- Bcl-2 Family
- Apoptosis
- VEGFR
- AMPK
- Parasite
- human p38 MAPK
- human colon cancer HCT116 cells
- human colon cancer HT-29 cells
- colorectal cancer
- Trypanosoma brucei rhodesiense
- human gastric cancer AGS cells
- human gastric cancer SGC-7901 cells
- myocardial infarction
- gastric cancer
- lung cancer
- Inhibitor
- inhibitor
- inhibit